Results 131 to 140 of about 55,552 (271)

Update on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program

Vascular Health and Risk Management, 2009
R Michael Kirchner, J Dawn AbbottDepartment of Cardiology, Rhode Island Hospital, Brown Medical School, Providence, RI, USAAbstract: Drug-eluting stents (DES) have had a major impact in interventional cardiology.
R Michael Kirchner, J Dawn Abbott
doaj  

Predictors of 12‐Month MACE Among Diabetic, Prediabetic, and Normoglycemic Patients Undergoing Elective Percutaneous Coronary Intervention: 10 Years' Experience From Tehran Heart Center

Health Science Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Background and Aims Elevated blood glucose levels in diabetes and prediabetes contribute to vascular inflammation and may increase the risk of major adverse cardiac events (MACE). We sought to evaluate the association between different glycemic statuses and 12‐month MACE in patients undergoing elective percutaneous coronary intervention (PCI ...
Ali Hosseinsabet, Nasrin Etesamifard, Akbar Shafiee, Arash Jalali, Amirhossein Heidari, Nazila Heidari, Hamid Ariannejad, Hassan Aghajani   +7 more
wiley   +1 more source

Drug-Eluting Stents in Primary Angioplasty Long-Term Clinical Outcomes [PDF]

, 2007
INTRODUCTION: The use of drug-eluting stents in the context of mechanical reperfusion following ST-segment elevation myocardial infarction (MI) was initially viewed with concern. The main fear was that the drugs' action in unstable lesions could increase
Bernardes, L, Cacela, D, Cruz Ferreira, R, Feliciano, J, Fernandes, R, Fiarresga, A, Patrício, L, Quininha, J, Sousa, L   +8 more
core  

Renal Denervation Suppresses Coronary Hyperconstricting Responses After Drug-Eluting Stent Implantation in Pigs In Vivo Through the Kidney–Brain–Heart Axis [PDF]

, 2017
Hironori Uzuka, Yasuharu Matsumoto, Kensuke Nishimiya, Kazuma Ohyama, Hideaki Suzuki, Hirokazu Amamizu, Susumu Morosawa, Michinori Hirano, Tomohiko Shindo, Yoku Kikuchi, Kiyotaka Hao, Takashi Shiroto, Kenta Ito, Jun Takahashi, Koji Fukuda, Satoshi Miyata, Yoshihito Funaki, Hatsue Ishibashi‐Ueda, Satoshi Yasuda, Hiroaki Shimokawa   +19 more
openalex   +1 more source

A Novel A‐Kinase‐Anchoring Protein 9 Variant in Premature Coronary Artery Disease: A Case Series

Molecular Genetics &Genomic Medicine, Volume 14, Issue 1, January 2026.
AKAP9 Q2136E mutation disrupts AKAP9–PRKAR2A interaction and may contribute to early‐onset CAD. ABSTRACT Background Familial premature coronary artery disease (CAD) is often associated with genetic variants. This study investigated potential causal variants in a Chinese pedigree with premature CAD. Methods In total, nine family members were included in
Yuemiao Jiao, Minxian Wang, Guifen Qiang, Li Zhao, Ziwei Xi, Yue Yu, Chengqian Yin, Guangyuan Song   +7 more
wiley   +1 more source

Analysis of Diagnostic Clues in a Rare Case of Ventricular Preexcitation Masking Occlusive Myocardial Infarction of the Left Anterior Descending Artery

Annals of Noninvasive Electrocardiology, Volume 31, Issue 1, January 2026.
This case report describes a potential electrocardiographic manifestation of ventricular pre‐excitation concealing a typical ST‐segment elevation myocardial infarction and provides a systematic analysis of the underlying pathophysiological mechanisms.
Honglin Ni, Xiaoli Zhang, Zhicheng Gao
wiley   +1 more source

Development and Micro Manufacturing of Coronary Stents in Hungary [PDF]

, 2006
Revascularisation by endovascular implant (stent) has great importance in the treatment of coronary artery diseases. Stents are high-technology implants that are the creation of the knowledge of health sciences, physics, chemistry, material science and
Dobránszky, János, Major, László, Nyitrai, Zsolt, Szabó, Barnabás   +3 more
core  

Drug‐Coated Balloons Versus Other Percutaneous Coronary Intervention Strategies in De Novo Coronary Artery Disease: A Systematic Review, Meta‐Analysis With Trial Sequential Analysis

Cardiovascular Therapeutics, Volume 2026, Issue 1, 2026.
Background Drug‐coated balloons (DCBs) present a viable option distinct from drug‐eluting stents (DESs) in addressing coronary artery disease (CAD), particularly when it comes to in‐stent restenosis (ISR) scenarios. The utilization of DCBs marks a significant deviation from traditional DES applications.
Yue Yu, Yue Miao Jiao, Yang Li, Ming Zhang, Guang Yuan Song, Cheng Qian Yin, Neetu Rawal   +6 more
wiley   +1 more source

Acute ST-Elevation Myocardial Infarction after Coronary Stent Fracture

Journal of Tehran University Heart Center, 2016
The invention of the drug-eluting stent (DES) has brought about revolutionary changes in the field of interventional cardiology. In the DES era, in-stent restenosis has declined but new issues such as stent thrombosis have emerged.
Abbasali Rafighdust, Ali Eshraghi
doaj  

Cardiac Arrest in a Pregnant Patient With Probable Spontaneous Coronary Artery Dissection and the Use of Targeted Temperature Management

Case Reports in Critical Care, Volume 2026, Issue 1, 2026.
Pregnancy‐associated spontaneous coronary artery dissection (SCAD) is a devastating cause of myocardial infarction that can lead to maternal and fetal demise. The use of targeted temperature management in a pregnant population post‐cardiac arrest is unclear given their exclusion from previous trials.
Stephanie Sibley, Paul Malik, Daniel Howes, Lipi Buch   +3 more
wiley   +1 more source